Opdivo starts to (measurably) work after around 2 months, give or take. In both of the IONIC cohorts, you wouldn't expect to see a response from Opdivo by itself, as patients have either stopped responding or it's a cancer where Opdivo doesn't work. So if it starts working, you would then monitor for stable, partial, complete responses for some months after that before making any public comment.
So the doctors should know if it's working around March next year, if recruitment proceeds quickly. BMS may have conditions on release of the data which may slow the release of results; this is not uncommon.
But NOX and BMS will want to move on this extremely quickly so we will be able to infer success very quickly too.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda and Opdivo IONIC Study First Patient Dosed
Ann: Veyonda and Opdivo IONIC Study First Patient Dosed, page-10
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
0.001(1.52%) |
Mkt cap ! $19.57M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.7¢ | $818 | 12.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17790 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 4049 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17790 | 0.067 |
1 | 24715 | 0.066 |
1 | 15000 | 0.065 |
1 | 10000 | 0.064 |
1 | 100000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 4049 | 1 |
0.079 | 11999 | 1 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.090 | 52000 | 3 |
Last trade - 15.44pm 12/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |